NUVLNuvalent Inc. Class A Common Stock
123.96USD0.00%Mkt Cap: 9.79B $P/E: —34d ago
Nuvalent, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer. Its lead product candidates are Zidesamtinib (NVL-520), a novel ROS1-selective inhibitor to ad…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap9.79B $
Enterprise Value8.51B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-450.07M $
Revenue/Share—
Last Price123.96 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees234
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-30.85
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B8.33
EPS (TTM)-6.06
EPS (Forward)-4.22
52W Range
71.13100% of range123.99
52W High123.99 USD
52W Low71.13 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-41.19%
ROA-22.51%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-312.79M $
CapEx (TTM)—
FCF Margin—
FCF Yield-1.84%
Net Debt-1.29B $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio16.14
Quick Ratio15.88
Book Value/Sh14.89 USD
Cash/Share16.30 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating3.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)124.00 USD
Upside (mean)+0.0%
Target Range124.00 USD – 124.00 USD
# Analysts9
Ownership
Shares Out.73.69M
Float49.11M
Insiders2.78%
Institutions113.30%
Short Interest
Short Ratio0.6d
Short % Float6.17%
Short % Out.3.68%
Shares Short2.91M
Short (prev mo.)5.24M
Technical
SMA 50114.66 (+8.1%)
SMA 200105.26 (+17.8%)
Beta1.14
S&P 52W Chg18.16%
Avg Vol (30d)3.74M
Avg Vol (10d)1.05M
Technical Indicators
RSI (14)67.5
MACD2.8409
MACD Signal3.5858
MACD Hist.-0.7449
BB Upper124.13 USD
BB Middle123.71 USD
BB Lower123.29 USD
BB Width0.68%
ATR (14)1.070 USD
Vol Ratio (20d)0.00x